Antidote Accessibility

Antidote Accessibility is a methodological construct within the domain of antidote availability that specifically addresses the ease and equity of reaching or obtaining an antidote given its distribution, cost, and regulatory status.

2

Publications

63

Citations

6

Authors

5

Institutions

Publications per year

2017–2026

0

Authors

6

  1. AD
    Alan D. Woolf

    Boston Children's Hospital, United States

    1 publications · 46 citations

    1

    h-index

  2. ML
    Marco L.A. Sivilotti

    Queen's University, Canada

    1 publications · 17 citations

    1

    h-index

  3. KC
    Keith Chrisanthus

    Boston Children's Hospital, United States

    1 publications · 46 citations

    1

    h-index

  4. RG
    Robert G. Peterson

    University of British Columbia, Canada

    1 publications · 17 citations

    1

    h-index

  5. JS
    Jeffrey S. Eisen

    Queen's University, Canada

    1 publications · 17 citations

    1

    h-index

1–5 of 6

Venues

  1. The American Journal of Emergency Medicine

    AJEM · 1 publications · 46 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 17 citations

    1

    h-index

1–2